新型藥物輸送系統 (NDDS) 的全球市場

Novel Drug Delivery Systems (NDDS)

出版日期: 2023年08月04日 | 出版商:

Global Industry Analysts, Inc. | 英文 492 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球新型藥物輸送系統 (NDDS) 市場將達到 610 億美元

在新冠肺炎 (COVID-19) 後商業環境發生變化的情況下，全球新型藥物輸送系統 (NDDS) 市場預計到 2022 年將達到 127 億美元，2022 年至 2030 年年複合成長率將達到21.6%，預計將達到2020年調整規模為610億美元。奈米顆粒是本報告分析的細分市場之一，預計年複合成長率21.1%，在分析期結束時達到 485 億美元。鑑於大流行後持續的復甦，栓塞顆粒細分市場的成長已重新確定為未來八年的年複合成長率為 23.7%。

美國市場預計為 48 億美元，中國預計年複合成長率為 26.4%

預計 2022 年美國新型藥物輸送系統 (NDDS) 市場規模將達到 48 億美元。中國作為世界第二大經濟體，預計到2030年市場規模將達到74億美元，2022年至2030年年複合成長率為26.4%。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 18.7% 和 19.8%。在歐洲，德國的年複合成長率預計約為 20.2%。

受訪企業示例

Alexza Pharmaceuticals
Ademtech SA
Acerus Pharmaceuticals Corporation
Adocia
Aerogen
Aktivax, Inc.
2C Tech
Acuitas Therapeutics
Applied Nanoparticles
Apogee Technology, Inc.
20Med Therapeutics
AnTolRx Inc.
Adipo Therapeutic
AcelRx Pharmaceuticals
Advanced NanoTherapies Inc.

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Novel Drug Delivery Systems (NDDS) Market to Reach $61 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$12.7 Billion in the year 2022, is projected to reach a revised size of US$61 Billion by 2030, growing at aCAGR of 21.6% over the period 2022-2030. Nanoparticles, one of the segments analyzed in the report, is projected to record 21.1% CAGR and reach US$48.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Embolization Particles segment is readjusted to a revised 23.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.8 Billion, While China is Forecast to Grow at 26.4% CAGR

The Novel Drug Delivery Systems (NDDS) market in the U.S. is estimated at US$4.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.4 Billion by the year 2030 trailing a CAGR of 26.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 19.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 20.2% CAGR.

Select Competitors (Total 238 Featured) -

Alexza Pharmaceuticals
Ademtech SA
Acerus Pharmaceuticals Corporation
Adocia
Aerogen
Aktivax, Inc.
2C Tech
Acuitas Therapeutics
Applied Nanoparticles
Apogee Technology, Inc.
20Med Therapeutics
AnTolRx Inc.
Adipo Therapeutic
AcelRx Pharmaceuticals
Advanced NanoTherapies Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Novel Drug Delivery Systems (NDDS) - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- 2020: A Year of Disruption & Transformation
- As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
- World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
- An Insight into Pandemic Impact on Pharmaceuticals Industry
- COVID-19 & Other Factors Shift Focus to Different Drug Delivery Approaches
- Novel Drug Delivery Systems Gain Interest Amid the Fight Against COVID-19
- Nanomaterial-enabled Novel Drug Delivery Systems Gain Interest in Vaccine Development
- Novel Drug Delivery System (NDDS): A Prelude
- Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach
- Patient Compliance: A Key Reason Garnering Interest in NDD
- Regulatory Process for Novel Drug Delivery Systems
- A Look into Current Areas of Research in Drug Delivery
- Market Outlook
- Nanotechnology-Enabled Drug Delivery: Primary Challenges
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Nanotechnology Bolsters Demand for NDDS
- Prospects Remain Encouraging
- Microfluidics Mediated NDDS Set to Make Gains
- Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
- Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
- List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
- Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine
- Dendrimers as Ideal Drug Delivery Agents
- List of Commercially Available Dendrimeric Products by Application Area
- High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
- Oral Thin Films Enhance NDDS Domain
- Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments
- Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- Number of New Cancer Cases and Deaths (in Million) by Region for 2020
- Global Breakdown of Total Number of Cancer Cases by Type: 2020
- Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors
- Uptrend in Gene Therapy Market Augurs Well for Market Growth
- Global Gene Therapy Market in US$ Million: 2020, 20223 and 2024
- Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
- Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment
- Global Annual Medical Cost of CVD in US$ Billion (2020-2030)
- NDD for Antimicrobial Drugs
- List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
- Nanotechnology Opens New Avenues in Antiretroviral Therapy
- Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies
- Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs
- Global HIV Prevalence Seeks Need for Novel Drug Delivery Systems: Number of People Living with AIDs (in Thousands) by Region for 2020
- Novel Drug Delivery Systems for CNS Therapeutics
- Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD
- Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases' Treatment
- Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy
- Exciting Immunology Developments Involving Graphene-based Nanomaterials
- Nanotechnology-Based Strategies for siRNA Grows in Popularity
- Nanoemulsions Begin to Make a Mark
- Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
- Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
- Recent Advancements in Polymeric Drug Delivery Systems
- Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
- Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
- SLNs in Pulmonary Delivery of Drugs
- Other Nanocarriers in Pulmonary Delivery
- Increasing Importance of Gold Nanoparticles in Targeted Drug Administration
- Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy
- Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
- World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 2: World 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- TABLE 3: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 4: World 8-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 6: World 8-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- TABLE 7: World Novel Drug Delivery Systems (NDDS) Market Analysis of Annual Sales in US$ Million for Years 2020 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 8: USA Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 9: USA 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
CANADA
- TABLE 10: Canada Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 11: Canada 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
JAPAN
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 12: Japan Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 13: Japan 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
CHINA
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 14: China Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 15: China 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
EUROPE
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 16: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 17: Europe 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- TABLE 18: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 19: Europe 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
FRANCE
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 20: France Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 21: France 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
GERMANY
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 22: Germany Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 23: Germany 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
ITALY
- TABLE 24: Italy Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 25: Italy 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
UNITED KINGDOM
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 26: UK Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 27: UK 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
REST OF EUROPE
- TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 29: Rest of Europe 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
ASIA-PACIFIC
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 31: Asia-Pacific 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030
REST OF WORLD
- TABLE 32: Rest of World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 33: Rest of World 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030